Procurement of Elosulfatase alfa (Vimizim)
Status
Active
Submission Deadline
133 days remaining
Contracting authority
HUS Group, the joint authority for Helsinki and Uusimaa — HUS Apteekki
Location
Finland
Procedure
Negotiated procedure without prior call for competition · Supplies
Category
Pharmaceutical products.
Published
Reference
hilma-EF-51944
Source
Seeking Elosulfatase alfa (Vimizim), a recombinant enzyme for treating Morquio A syndrome. The estimated cost is approximately 3 million Euros.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Additional details
Electronic Submission
Required
Legal Basis
32014L0024